AAAAAA
Results:
1-20
|
Results: 20
Authors:
Sheehy, N
Vaughan, CJ
Delanty, N
Citation: N. Sheehy et al., Statins and neuroprotection, EXPERT OP I, 10(10), 2001, pp. 1847-1853
Authors:
Vaughan, CJ
Delanty, N
Basson, CT
Citation: Cj. Vaughan et al., Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?, CNS DRUGS, 15(8), 2001, pp. 589-596
Authors:
Majid, A
Delanty, N
Kantor, J
Citation: A. Majid et al., Antiplatelet agents for secondary prevention of ischemic stroke, ANN PHARMAC, 35(10), 2001, pp. 1241-1247
Authors:
Delanty, N
French, JA
Labar, DR
Pedley, TA
Rowan, AJ
Citation: N. Delanty et al., Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients, SEIZURE-E J, 10(2), 2001, pp. 116-119
Authors:
Vaughan, CJ
Delanty, N
Basson, CT
Citation: Cj. Vaughan et al., Statin therapy and stroke prevention, CURR OPIN C, 16(4), 2001, pp. 219-224
Authors:
Taylor, DC
McMackin, D
Staunton, H
Delanty, N
Phillips, J
Citation: Dc. Taylor et al., Patients' aims for epilepsy surgery: Desires beyond seizure freedom, EPILEPSIA, 42(5), 2001, pp. 629-633
Authors:
Murphy, K
Delanty, N
Citation: K. Murphy et N. Delanty, Drug-induced seizures - General principles in assessment, management and prevention, CNS DRUGS, 14(2), 2000, pp. 135-146
Authors:
Vaughan, CJ
Delanty, N
Citation: Cj. Vaughan et N. Delanty, Hypertensive emergencies, LANCET, 356(9227), 2000, pp. 411-417
Authors:
Vaughan, CJ
Delanty, N
Citation: Cj. Vaughan et N. Delanty, Effects of statins on ischemic stroke: Neuroprotection and/or triggering of apoptotic damage? Response, STROKE, 31(4), 2000, pp. 989-990
Authors:
Vaughan, CJ
Delanty, N
Citation: Cj. Vaughan et N. Delanty, Nitric oxide in acute ischaemic stroke, J NE NE PSY, 68(1), 2000, pp. 123-123
Authors:
Delanty, N
Dichter, MA
Citation: N. Delanty et Ma. Dichter, Antioxidant therapy in neurologic disease, ARCH NEUROL, 57(9), 2000, pp. 1265-1270
Authors:
Pratico, D
Delanty, N
Citation: D. Pratico et N. Delanty, Oxidative injury in diseases of the central nervous system: Focus on Alzheimer's disease, AM J MED, 109(7), 2000, pp. 577-585
Authors:
Mohler, ER
Delanty, N
Rader, DJ
Raps, EC
Citation: Er. Mohler et al., Statins and cerebrovascular disease: plaque attack to prevent brain attack, VASC MED, 4(4), 1999, pp. 269-272
Authors:
Delanty, N
Georgescu, L
Lynch, T
Paget, S
Stubgen, JP
Citation: N. Delanty et al., Synovial fluid polymerase chain reaction as an aid to the diagnosis of central nervous system Whipple's disease, ANN NEUROL, 45(1), 1999, pp. 137-138
Authors:
Reilly, MP
Moran, N
Meagher, E
Delanty, N
Cucchiara, AE
Lawson, JA
Catella-Lawson, F
Citation: Mp. Reilly et al., A randomized, placebo-controlled, crossover study of E5510 and aspirin in healthy volunteers, J CARDIO PH, 33(1), 1999, pp. 12-18
Authors:
Vaughan, CJ
Delanty, N
Citation: Cj. Vaughan et N. Delanty, Neuroprotective properties of statins in cerebral ischemia and stroke, STROKE, 30(9), 1999, pp. 1969-1973
Authors:
Delanty, N
Citation: N. Delanty, Secondary prevention after cerebral ischaemia of presumed arterial origin:is aspirin still the touchstone?, J NE NE PSY, 67(6), 1999, pp. 832-832
Authors:
Reilly, MP
Pratico, D
Lanken, P
Delanty, N
Rockach, J
Lawson, J
FitzGerald, GA
Citation: Mp. Reilly et al., Isoprostanes in the assessment of oxidant stress in vivo, CUR INF RES, 1999, pp. 127-139
Authors:
Delanty, N
French, JA
Citation: N. Delanty et Ja. French, New options in epilepsy pharmacotherapy, FORMULARY, 33(12), 1998, pp. 1190
Authors:
Reilly, MP
Pratico, D
Delanty, N
DiMinno, G
Tremoli, E
Rader, D
Kapoor, S
Rokach, J
Lawson, J
FitzGerald, GA
Citation: Mp. Reilly et al., Increased formation of distinct F-2 isoprostanes in hypercholesterolemia, CIRCULATION, 98(25), 1998, pp. 2822-2828
Risultati:
1-20
|